Tom 17, Nr 3 (2021)
Obrazy w medycynie
Opublikowany online: 2021-10-14
Wyświetlenia strony
4775
Wyświetlenia/pobrania artykułu
268
Pierwotnie postępująca postać stwardnienia rozsianego (PPMS, primary progressive multiple sclerosis)
Pol. Przegl. Neurol 2021;17(3):135-137.
Streszczenie
Brak
Referencje
- Montalban X. Primary progressive multiple sclerosis. Curr Opin Neurol. 2005; 18(3): 261–266.
- Rice CM, Cottrell D, Wilkins A, et al. Primary progressive multiple sclerosis: progress and challenges. J Neurol Neurosurg Psychiatry. 2013; 84(10): 1100–1106.
- Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018; 17(2): 162–173.
- Cortese R, Collorone S, Ciccarelli O, et al. Advances in brain imaging in multiple sclerosis. Ther Adv Neurol Disord. 2019; 12: 1756286419859722.
- Feng JJ, Ontaneda D. Treating primary-progressive multiple sclerosis: potential of ocrelizumab and review of B-cell therapies. Degener Neurol Neuromuscul Dis. 2017; 7: 31–45.
- Mancinelli CR, Rossi NDe, Capra R. Ocrelizumab for the treatment of multiple sclerosis: safety, efficacy, and pharmacology. Ther Clin Risk Manag. 2021; 17: 765–776.
